Oxidants-induced high levels of nitric oxide impair the antioxidative property of molybdenum nanoparticles in HUVE cells

In recent years, there has been significant interest in the biomedical potential of redox-active molybdenum nanoparticles (Mo NPs) due to their varied responses from oxidative to antioxidative. Our knowledge of the bio-response of Mo NPs in endothelial cells is lacking. We, therefore, are prompted to examine the biocompatibility of well-characterized Mo NPs in human endothelial (HUVE) cells and their potential antioxidative response against standard oxidants- tert-butyl hydroperoxide (t-BHP) and hydrogen peroxide (H₂O₂). The study found that Mo NPs were highly biocompatible in HUVE cells and enhanced cellular antioxidant glutathione (GSH), significantly protecting cells against exogenous oxidants. Moreover, Mo NPs significantly restored the loss of mitochondrial membrane potential (MMP) determined by the Rh123 probe. They decreased reactive oxygen species (ROS) levels as measured by DHE and DCFH-DA probes. In light of Mo involvement in the nitric oxide (NO) metabolism and dependency of HUVE cells on NO signaling, intracellular NO was determined using DAR-2 fluorescent dye and the Griess assay. NO was not produced significantly by Mo NPs alone or t-BHP or H₂O₂. However, NO generation was significantly high when HUVE cells were co-exposed with Mo NPs and exogenous oxidants. Although the exact mechanism is unclear to us, our study concludes that the enhanced generation of NO under the co-exposure of oxidants with Mo NPs can impair the potential antioxidative property of Mo NPs, especially in endothelial cells. The study also suggests that NO modulatory strategies can improve and broaden the antioxidative properties of Mo-based nanoparticles.